Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 1/2001

Content (8 Articles)

ORIGINAL ARTICLE

Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl -positive leukemia in mice

Lin He, Hanping Feng, Amy Raymond, Meghan Kreeger, Yi Zeng, Michael Graner, Luke Whitesell, Emmanuel Katsanis

ORIGINAL ARTICLE

In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody

Rob C. Roovers, Edith van der Linden, Adriaan P. de Bruïne, Jan-Willem Arends, Hennie R. Hoogenboom

ORIGINAL ARTICLE

Monocyte-chemoattractant-protein-1-mediated migration of human monocytes towards blasts from patients with acute myeloid leukemia

Maria C. J. C. Legdeur, Marjolein G. Broekhoven, Gerrit J. Schuurhuis, Robert H. J. Beelen, Gert J. Ossenkoppele

ORIGINAL ARTICLE

Effect of interferon-γ on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells

Eui-Cheol Shin, Woo-Chul Shin, Youjeong Choi, Hoguen Kim, Jeon Han Park, Se Jong Kim

ORIGINAL ARTICLE

The growth-regulatory role of B-cell-specific activator protein in NZB malignant B-1 cells

Siew Yen Chong, Ming Zhang, Yi-Chu Lin, Frederick Coffman, Zenaida Garcia, Nicholas Ponzio, Elizabeth S. Raveche

REVIEW

A listing of human tumor antigens recognized by T cells

Nicolina Renkvist, Chiara Castelli, Paul F. Robbins, Giorgio Parmiani

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine